Bosh sahifaGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Yopilish kursi
2 127,70 ₹
Kunlik diapazon
2 117,30 ₹ - 2 156,90 ₹
Yillik diapazon
1 275,50 ₹ - 2 284,80 ₹
Bozor kapitalizatsiyasi
600,24 mlrd INR
Oʻrtacha hajm
717,15 ming
Narx/foyda
79,65
Dividend daromadliligi
0,12%
Asosiy maydon
NSE
Yangiliklarda
MSN
1 kun oldin
Glenmark, Texmaco Rail shares in focus on the last day to buy for dividend eligibility
3,67%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 32,64 mlrd | 0,62% |
Joriy xarajat | 17,98 mlrd | 8,09% |
Sof foyda | 468,71 mln | -86,23% |
Sof foyda marjasi | 1,44 | -86,27% |
Har bir ulushga tushum | 7,29 | -39,58% |
EBITDA | 5,72 mlrd | -8,92% |
Amaldagi soliq stavkasi | 50,85% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 17,05 mlrd | 2,76% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 88,49 mlrd | — |
Tarqatilgan aksiyalar | 282,36 mln | — |
Narxi/balansdagi bahosi | 6,99 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 9,95% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 468,71 mln | -86,23% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
Tashkil etilgan
18-noy, 1977
Xodimlar soni
15 800
